Drug repositioning or Drug repurposing is a way to deal with quicken the Drug Discovery process through the distinguishing proof of a novel clinical use for a current medication endorsed for an alternate sign. The expanded achievement and uses of Drug repurposing can be considered as one of the results of poly pharmacology and it speaks to a sign of the move from a solitary to multitarget worldview in Drug Discovery.
Drug Repurposing can lessen social insurance costs, given how relentless, tedious, and expensive again sedate revelation ventures have been. Drug-candidate molecules that have been appeared as being protected, yet inadequately successful for the planned objective, can be considered for different targets, thus perhaps diminishing the expenses of clinical preliminary. The expanding sum and accessibility of open and open source databases, information, calculations, and servers have empowered more members of Drug repurposing ventures.
Sub Tracks
· Basis of Drug Repurposing
· Computer-Assisted Drug Repurposing
· Holistic Drug Targeting
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
